GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Ending Cash Position

HLB Science (XKRX:343090) Ending Cash Position : ₩0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Ending Cash Position?

HLB Science's Ending Cash Position for the quarter that ended in . 20 was ₩0.00 Mil.

HLB Science's annual Ending Cash Position increased from . 20 (₩0.00 Mil) to Dec. 2022 (₩4,229.55 Mil) but then declined from Dec. 2022 (₩4,229.55 Mil) to Dec. 2023 (₩276.55 Mil).

HLB Science Ending Cash Position Historical Data

The historical data trend for HLB Science's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Ending Cash Position Chart

HLB Science Annual Data
Trend Dec22 Dec23
Ending Cash Position
4,229.55 276.55

HLB Science Quarterly Data
Ending Cash Position

HLB Science Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

HLB Science's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4229.549+-3953
=276.55

HLB Science's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

HLB Science Ending Cash Position Related Terms

Thank you for viewing the detailed overview of HLB Science's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Ending Cash Position
Comparable Companies
XKRX:950220 XKRX:283100 XKRX:322970 XKRX:215380 XKRX:179530 XKRX:446440 XKRX:251280 XKRX:208340 XKRX:344860 XKRX:072520 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
Website
http://www.hlbscience.com
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines